Clinical Trials on Thymoma Type B3

Total 55803 results

Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) (Style)

Thymic Carcinoma | Type B3 Thymoma

Italy
European Organisation for Research and Treatment...
ETOP IBCSG Partners Foundation

Active, not recruiting

Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) (NIVOTHYM)

Thymic Carcinoma | Thymoma Type B3

Netherlands, Spain, France, Belgium, United Kingdom, Switzerland
MedSIR
Merck Sharp & Dohme LLC

Active, not recruiting

Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents (PECATI)

Metastatic Thymic Carcinoma | Thymoma Type B3

Spain, France, Italy
Istituto Clinico Humanitas

Completed

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy (RESOUND)

Melanoma | Sarcoma | Ovarian Cancer | Thymic Carcinoma | Pancreas Cancer | Thymoma Type B3 | Thymoma Type B2

Italy
National Cancer Institute (NCI)

Terminated

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Invasive Thymoma and Thymic Carcinoma | Recurrent Thymoma and Thymic Carcinoma | Stage III Thymoma | Stage IVA Thymoma | Stage IVB Thymoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Stage III Thymoma AJCC v8 | Stage IIIA Thymoma AJCC v8 | Stage IIIB Thymoma AJCC v8 | Stage IV Thymoma AJCC v8 | Stage IVA Thymoma AJCC v8 | Stage IVB Thymoma AJCC v8 | Unresectable Thymic Carcinoma

United States
Tiziana Life Sciences LTD

Terminated

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

Malignant Thymoma

United States, Italy
Yale University

Withdrawn

Thymectomy With and Without Povidone-iodine Pleural Lavage in Stage IVA Thymic Malignancies

Stage IVA Thymoma
Prof. Dr. Berthold Schalke
Crolll Gmbh

Completed

Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

Primary Inoperable Thymoma | Local Recurrent Thymoma

Germany
Tang-Du Hospital

Recruiting

Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma

Thymoma and Thymic Carcinoma

China
Peng Liu

Not yet recruiting

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma

China
Armando Santoro, MD

Completed

Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy (ONC-2010-001)

Thymoma and Thymic Carcinoma

Italy
Fudan University

Recruiting

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Thymoma and Thymic Carcinoma

China
Chulalongkorn University

Completed

Characteristics of Patients With Thymoma in Chulalongkorn Hospital

Thymoma Staging | Clinical Presentations | Associated Disorders | Laboratory Findings

Thailand
Jian Chen

Recruiting

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy

China
National Cancer Institute (NCI)

Recruiting

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Thymic Epithelial Tumor | Thymic Cancer | Recurrent Thymoma

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Thymoma and Thymic Carcinoma

United States, South Africa
Institut Curie

Recruiting

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC)

Thymoma Malignant Recurrent

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Thymoma | Recurrent Malignant Thymoma

United States
Sun Yat-sen University

Active, not recruiting

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Thymoma and Thymic Carcinoma

China
National Cancer Institute (NCI)

Recruiting

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Thymic Epithelial Tumor | Thymic Cancer | Recurrent Thymoma

United States
Fudan University

Completed

Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors

Thymoma and Thymic Carcinoma

China
Erasmus Medical Center
Hospices Civils de Lyon; Maastro Clinic, The Netherlands

Recruiting

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors (INTHYM)

Thymic Carcinoma | Thymoma | Thymic Epithelial Tumor | Thymoma and Thymic Carcinoma

Netherlands
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Robot-assisted vs VATS for Thymoma

Thymoma

China
Zhejiang Cancer Hospital

Recruiting

Single Cell Sequencing Analysis of Thymoma

Thymoma

China
National Cancer Institute (NCI)
Indiana University School of Medicine

Active, not recruiting

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

Thymoma | Thymus Neoplasms

United States
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-Pentixafor PET/CT for Thymoma

Thymoma

China
Fudan University

Recruiting

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Thymoma

China
Novartis Pharmaceuticals

Completed

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Thymoma

Germany
Istituto Clinico Humanitas

Completed

Biology of Thymic Tumors

Thymoma

Italy
Valley Health System

Completed

Preoperative Treatment of Patients With High Risk Thymoma

Thymoma

United States, Canada
Shanghai Zhongshan Hospital

Recruiting

IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

Thymoma

China
Patrick Joseph Loehrer Sr.
Novartis Pharmaceuticals

Completed

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

Thymoma

United States
Cancer Institute and Hospital, Chinese Academy...
Beijing Hospital; 309th Hospital of Chinese People's Liberation Army

Unknown

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

Thymoma

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Thymic Carcinoma

China
Military Hospital 103
Nguyen Truong Giang

Completed

Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors

Thymoma
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Thymus Neoplasms

China
National Cancer Institute (NCI)

Terminated

A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Thymic Carcinoma | Thymoma

United States
Third Military Medical University

Completed

Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment

Thymoma | Thymic Tumor

China
Indiana University School of Medicine
Genentech, Inc.

Completed

A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Thymoma | Thymic Cancer

United States
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 in Patients With Advanced Thymic Tumors

Thymic Tumors

China
Shanghai Zhongshan Hospital
Shanghai Minhang Central Hospital; Xuhui Central Hospital, Shanghai; Zhongshan... and other collaborators

Completed

Surgery for Masaoka-Koga I-II Thymoma

Thymoma | Masaoka Stage I | Masaoka Stage II

China
Weill Medical College of Cornell University
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Terminated

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Thymic Carcinoma

United States
Tiziana Life Sciences LTD

Terminated

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Thymic Carcinoma

United States, France, Italy
Hoffmann-La Roche

Active, not recruiting

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Carcinoma, Thymic

China
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Terminated

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Thymic Carcinoma

China
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Thymic Carcinoma | Thymoma

United States
Tianjin Medical University Cancer Institute and...

Withdrawn

Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases

Thymoma | Autoimmune Disease

China
Johannes Gutenberg University Mainz

Completed

Cerament Treatment of Fracture Defects (CERTiFy)

AO 41-B2 and AO 41-B3 Tibia Fractures

Germany
Heather Wakelee
Celgene

Completed

A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies

Thymic Carcinoma | Thymoma | Thymus Cancer

United States

Clinical Trials on Thymoma Type B3

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations